Kinovi

Kinovi is opening a new frontier in the saga of drug discovery. Join us on our quest to alleviate suffering, increase longevity, and improve the quality of life for countless human beings. By providing drug hunters with the means to discover a new generation of medicines, more people will receive the treatment they need. We are focusing on research that involves transmembrane proteins. These represent 30% of the druggable proteins in the human genome and have resulted in 45% of approved medicines. Despite this success, scientists still struggle to study them effectively. As a result, countless diseases remain untreated. This will change. Our Confidynt™ platform combines exclusive membrane protein technology with cutting-edge sensors, allowing transmembrane proteins to be studied in their native state. Scientists can therefore perform sensitive measurements of drug-induced conformational dynamics in a simple and reproducible manner. When used for drug discovery efforts, Confidynt™ can deliver lead candidates with a higher probability of clinical We are always excited to bring on innovative professionals. Find out more at